190 related articles for article (PubMed ID: 28824725)
1. Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center.
Kytola V; Topaloglu U; Miller LD; Bitting RL; Goodman MM; D Agostino RB; Desnoyers RJ; Albright C; Yacoub G; Qasem SA; DeYoung B; Thorsson V; Shmulevich I; Yang M; Shcherban A; Pagni M; Liu L; Nykter M; Chen K; Hawkins GA; Grant SC; Petty WJ; Alistar AT; Levine EA; Staren ED; Langefeld CD; Miller V; Singal G; Petro RM; Robinson M; Blackstock W; Powell BL; Wagner LI; Foley KL; Abraham E; Pasche B; Zhang W
Theranostics; 2017; 7(11):2914-2923. PubMed ID: 28824725
[No Abstract] [Full Text] [Related]
2. Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors.
Mechanic LE; Bowman ED; Welsh JA; Khan MA; Hagiwara N; Enewold L; Shields PG; Burdette L; Chanock S; Harris CC
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):214-22. PubMed ID: 17301252
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations in the DNA repairome in prostate cancers in African Americans and Caucasians.
Yadav S; Anbalagan M; Baddoo M; Chellamuthu VK; Mukhopadhyay S; Woods C; Jiang W; Moroz K; Flemington EK; Makridakis N
Oncogene; 2020 May; 39(21):4299-4311. PubMed ID: 32300177
[TBL] [Abstract][Full Text] [Related]
4. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations.
Campbell JD; Lathan C; Sholl L; Ducar M; Vega M; Sunkavalli A; Lin L; Hanna M; Schubert L; Thorner A; Faris N; Williams DR; Osarogiagbon RU; van Hummelen P; Meyerson M; MacConaill L
JAMA Oncol; 2017 Jun; 3(6):801-809. PubMed ID: 28114446
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
[TBL] [Abstract][Full Text] [Related]
8. Genomic Profiling of Prostate Cancers from Men with African and European Ancestry.
Koga Y; Song H; Chalmers ZR; Newberg J; Kim E; Carrot-Zhang J; Piou D; Polak P; Abdulkadir SA; Ziv E; Meyerson M; Frampton GM; Campbell JD; Huang FW
Clin Cancer Res; 2020 Sep; 26(17):4651-4660. PubMed ID: 32651179
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution.
Sylvester BE; Huo D; Khramtsov A; Zhang J; Smalling RV; Olugbile S; Polite BN; Olopade OI
Clin Cancer Res; 2012 Jan; 18(2):350-9. PubMed ID: 22114137
[TBL] [Abstract][Full Text] [Related]
10. Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities.
Marima R; Hull R; Mbeje M; Molefi T; Mathabe K; Elbagory AM; Demetriou D; Dlamini Z
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054814
[TBL] [Abstract][Full Text] [Related]
11. Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma.
Lee MJ; Koff JL; Switchenko JM; Jhaney CI; Harkins RA; Patel SP; Dave SS; Flowers CR
Cancer; 2020 Aug; 126(15):3493-3503. PubMed ID: 32469082
[TBL] [Abstract][Full Text] [Related]
12. Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers.
Yuan J; Hu Z; Mahal BA; Zhao SD; Kensler KH; Pi J; Hu X; Zhang Y; Wang Y; Jiang J; Li C; Zhong X; Montone KT; Guan G; Tanyi JL; Fan Y; Xu X; Morgan MA; Long M; Zhang Y; Zhang R; Sood AK; Rebbeck TR; Dang CV; Zhang L
Cancer Cell; 2018 Oct; 34(4):549-560.e9. PubMed ID: 30300578
[TBL] [Abstract][Full Text] [Related]
13. Somatic gene mutations in African Americans may predict worse outcomes in colorectal cancer.
Kang M; Shen XJ; Kim S; Araujo-Perez F; Galanko JA; Martin CF; Sandler RS; Keku TO
Cancer Biomark; 2013; 13(5):359-66. PubMed ID: 24440976
[TBL] [Abstract][Full Text] [Related]
14. Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.
van Beek EJAH; Hernandez JM; Goldman DA; Davis JL; McLaughlin K; Ripley RT; Kim TS; Tang LH; Hechtman JF; Zheng J; Capanu M; Schultz N; Hyman DM; Ladanyi M; Berger MF; Solit DB; Janjigian YY; Strong VE
Ann Surg Oncol; 2018 Jul; 25(7):2027-2033. PubMed ID: 29725898
[TBL] [Abstract][Full Text] [Related]
15. TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer.
Kelsey KT; Hirao T; Hirao S; Devi-Ashok T; Nelson HH; Andrew A; Colt J; Baris D; Morris JS; Schned A; Karagas M
Int J Cancer; 2005 Nov; 117(3):370-5. PubMed ID: 15906354
[TBL] [Abstract][Full Text] [Related]
16. Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer.
Bellmunt J; Kim J; Reardon B; Perera-Bel J; Orsola A; Rodriguez-Vida A; Wankowicz SA; Bowden M; Barletta JA; Morote J; de Torres I; Juanpere N; Lloreta-Trull J; Hernandez S; Mouw KW; Taplin ME; Cejas P; Long HW; Van Allen EM; Getz G; Kwiatkowski DJ
Cancer Res; 2020 Oct; 80(20):4476-4486. PubMed ID: 32868381
[TBL] [Abstract][Full Text] [Related]
17. Distinct Genomic Alterations in Prostate Tumors Derived from African American Men.
Liu W; Zheng SL; Na R; Wei L; Sun J; Gallagher J; Wei J; Resurreccion WK; Ernst S; Sfanos KS; Isaacs WB; Xu J
Mol Cancer Res; 2020 Dec; 18(12):1815-1824. PubMed ID: 33115829
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
Nanda R; Schumm LP; Cummings S; Fackenthal JD; Sveen L; Ademuyiwa F; Cobleigh M; Esserman L; Lindor NM; Neuhausen SL; Olopade OI
JAMA; 2005 Oct; 294(15):1925-33. PubMed ID: 16234499
[TBL] [Abstract][Full Text] [Related]
19. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
Manzano RG; Catalan-Latorre A; Brugarolas A
BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.
Moss TJ; Qi Y; Xi L; Peng B; Kim TB; Ezzedine NE; Mosqueda ME; Guo CC; Czerniak BA; Ittmann M; Wheeler DA; Lerner SP; Matin SF
Eur Urol; 2017 Oct; 72(4):641-649. PubMed ID: 28601352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
